We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.74%
2 Healthcare 2.42%
3 Financials 2.31%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AQB icon
11851
CALL
AquaBounty Technologies
AQB
$7.67M
$134K ﹤0.01%
3,585
-1,790
-33% -$62.2K
CLGN icon
11852
CALL
CollPlant Biotechnologies
CLGN
$6.23M
$134K ﹤0.01%
+11,700
New +$129K
CCV.WS
11853
DELISTED
Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCV.WS
$134K ﹤0.01%
220,036
+912
+0.4% +$675
IDEX
11854
CALL
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$134K ﹤0.01%
960
-1,890
-66% -$241K
TINV.U
11855
DELISTED
Tiga Acquisition Corp. Units, each consisting of one Class A ordinary share and one half of one warrant
TINV.U
$134K ﹤0.01%
12,884
+239
+2% +$2.5K
QNGY
11856
CALL
DELISTED
Quanergy Systems, Inc.
QNGY
$134K ﹤0.01%
3,635
+55
+2% +$6.15K
LFTRU
11857
DELISTED
Lefteris Acquisition Corp. Unit
LFTRU
$134K ﹤0.01%
13,543
+145
+1% +$1.44K
EPIX
11858
CALL
DELISTED
ESSA Pharma
EPIX
$133K ﹤0.01%
21,600
+10,200
+89% +$89.7K
HOOK
11859
PUT
DELISTED
HOOKIPA Pharma
HOOK
$133K ﹤0.01%
5,840
+3,390
+138% +$60.8K
SEGG
11860
PUT
Sports Entertainment Gaming Global Corp
SEGG
$8.21M
$133K ﹤0.01%
30
+7
+30% +$40.1K
OTLK icon
11861
Outlook Therapeutics
OTLK
$141M
$133K ﹤0.01%
3,724
-165
-4% -$5.15K
PCYO icon
11862
CALL
Pure Cycle
PCYO
$271M
$133K ﹤0.01%
11,100
-6,800
-38% -$84.2K
VIRX
11863
PUT
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$133K ﹤0.01%
27,900
-10,872
-28% -$32.8K
BTCY
11864
DELISTED
Biotricity, Inc. Common Stock
BTCY
$133K ﹤0.01%
+9,735
New +$169K
ALTUU
11865
DELISTED
Altitude Acquisition Corp Unit
ALTUU
$133K ﹤0.01%
13,220
-1
-0% -$10
SPKBW
11866
DELISTED
Silver Spike Acquisition Corp II Warrant
SPKBW
$133K ﹤0.01%
429,997
-162,620
-27% -$71K
LOTZ
11867
PUT
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$133K ﹤0.01%
97,200
-57,800
-37% -$109K
FHLTU
11868
DELISTED
Future Health ESG Corp. Unit
FHLTU
$133K ﹤0.01%
108,075
-310,767
-74% -$3.11M
ATNM icon
11869
PUT
Actinium Pharmaceuticals
ATNM
$32.6M
$132K ﹤0.01%
25,900
-6,100
-19% -$32.1K
EDZ icon
11870
CALL
Direxion Daily MSCI Emerging Markets Bear 3X ETF
EDZ
$18.6M
$132K ﹤0.01%
1,230
-600
-33% -$61.5K
LYG icon
11871
PUT
Lloyds Banking Group
LYG
$90.1B
$132K ﹤0.01%
54,800
-1,700
-3% -$4.52K
SCYX icon
11872
SCYNEXIS
SCYX
$51.5M
$132K ﹤0.01%
4,217
+2,060
+96% +$78.8K
TRTX
11873
PUT
TPG RE Finance Trust
TRTX
$609M
$132K ﹤0.01%
+11,200
New +$136K
ZFOXW
11874
DELISTED
ZeroFox Holdings, Inc. Warrants
ZFOXW
$132K ﹤0.01%
433,468
-138
-0% -$62
RONI.WS
11875
DELISTED
Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
RONI.WS
$132K ﹤0.01%
212,709
+205
+0.1% +$194

Similar funds

Ken Griffin's Q1 2022 Portfolio in Review

As of Q1 2022, Ken Griffin held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Ken Griffin deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Ken Griffin's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Ken Griffin's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Ken Griffin fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Ken Griffin's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Ken Griffin opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Ken Griffin's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.